Literature DB >> 1627548

Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity.

S Imaoka1, Y Imai, T Shimada, Y Funae.   

Abstract

Cytochrome P-450 coded for by the 3A gene family requires specific conditions in a reconstituted system, if its catalytic activity is to be efficient. We investigated the mechanism of activation of the catalytic activity of cytochrome P450 3A by phospholipids. Rat P450 PB-1 (3A2), human P450NF (3A4), and rabbit P450 3c (3A6) were used. They had low activity in a reconstituted system (system I) with dilauroylphosphatidylcholine (DLPC) but had high activity with a mixture of phospholipids (DLPC, dioleoylphosphatidylcholine, and phosphatidylserine) and sodium cholate (system II). P450 3A forms are cationic (having a high content of lysine residues) and needed the anionic phospholipid phosphatidylserine to have sufficient activity. Double-reciprocal plots of the metabolic rate of cytochrome P-450 versus the concentration of NADPH-cytochrome P-450 reductase showed that cytochrome P-450 and the reductase interacted more in system II than in system I. P450 PB-1 did not absorb at 450 nm in the presence of reductase, CO, DLPC, and NADPH, although other cytochrome P-450s absorbed at around 450 nm in such a mixture. However, P450 PB-1 was reduced in the presence of the phospholipid mixture and sodium cholate instead of DLPC. These results suggested that the stimulation of catalytic activity by phospholipids involved increased interaction between cytochrome P-450 and the reductase. Studies of proteolytic digestion and chemical cross-linking in systems I and II showed that a P450 3A form needed disaggregation of cytochrome P-450 and/or the reductase, not the formation of an aggregated complex necessary for the catalytic activity of other cytochrome P-450s.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627548     DOI: 10.1021/bi00141a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450.

Authors:  Mirza Bojić; Carl A Sedgeman; Leslie D Nagy; F Peter Guengerich
Journal:  Eur J Pharm Sci       Date:  2015-03-31       Impact factor: 4.384

Review 2.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 3.  Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450.

Authors:  E H Oliw; J Bylund; C Herman
Journal:  Lipids       Date:  1996-10       Impact factor: 1.880

4.  Two surfaces of cytochrome b5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries.

Authors:  Hwei-Ming Peng; Richard J Auchus
Journal:  Arch Biochem Biophys       Date:  2013-11-17       Impact factor: 4.013

5.  Effects of membrane mimetics on cytochrome P450-cytochrome b5 interactions characterized by NMR spectroscopy.

Authors:  Meng Zhang; Rui Huang; Sang-Choul Im; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

6.  Enhancement of bile acid pool size, synthesis and secretion by epomediol in the rat.

Authors:  J L Mauriz; M J Cuevas; M Y El-Mir; M Almar; P S Collado; J Gonzalez-Gallego
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

7.  Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.

Authors:  J Wójcicki; T Sulikowski; M Wójcicki; M Droździk; B Gawrońska-Szklarz; B Barcew-Wiszniewska; J Skowron; L Rózewicka
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 8.  Recent Structural Insights into Cytochrome P450 Function.

Authors:  F Peter Guengerich; Michael R Waterman; Martin Egli
Journal:  Trends Pharmacol Sci       Date:  2016-06-04       Impact factor: 14.819

9.  Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.

Authors:  M S Shet; C W Fisher; P L Holmans; R W Estabrook
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Comparison of CYP3A4 and CYP3A5: the effects of cytochrome b5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities.

Authors:  Su-Jun Lee; Joyce A Goldstein
Journal:  Drug Metab Pharmacokinet       Date:  2012-06-12       Impact factor: 3.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.